secwatch.observer — SEC 8-K summary
======================================

Issuer:     Curanex Pharmaceuticals Inc (CURX)
CIK:        0002025942
Form:       8-K
Filed at:   2025-11-06T23:59:59+00:00
Accession:  0001493152-25-021028
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Curanex Pharmaceuticals receives Nasdaq bid price deficiency notice; 180-day cure period
--------------------------------------------------------------------------------

- Received Nasdaq notice on Nov 5, 2025 for bid price below $1.00 for 30 consecutive days.
- Has until May 4, 2026 (180 days) to regain compliance with Minimum Bid Price.
- If not cured, may qualify for additional 180-day period if eligible and cures with reverse split if needed.
- Stock continues trading under symbol CURX on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2025942/000149315225021028/0001493152-25-021028-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2025942/000149315225021028/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-021028

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer